Post by Biogen

1,287,650 followers

Today, we announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for an investigational therapy for spinal muscular atrophy (SMA).    This designation marks important progress toward bringing a potential new option to people living with SMA. Learn more: https://lnkd.in/e2Md9ajJ #News

Post content

Video Content